Dr. Lathrop is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7979 Wurzbach Rd
San Antonio, TX 78229Phone+1 210-450-1143Fax+1 210-450-0407
Education & Training
- University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineFellowship, Hematology and Medical Oncology, 2011 - 2014
- University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineResidency, Internal Medicine, 2007 - 2010
- The University of Texas Health Science Center at San AntonioClass of 2007
Certifications & Licensure
- TX State Medical License 2009 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Host Immune Response to Novel RNA COVID-19 Vaccination Start of enrollment: 2021 Feb 24
Publications & Presentations
PubMed
- Genomic and transcriptomic landscape of HER2-low breast cancer.Rani Bansal, Tolulope Adeyelu, Andrew Elliott, Phillip Walker, Matias A Bustos
Breast Cancer Research and Treatment. 2025-01-01 - 5 citationsSacituzumab Govitecan in patients with breast cancer brain metastases and recurrent glioblastoma: a phase 0 window-of-opportunity trial.Henriette U Balinda, William J Kelly, Virginia G Kaklamani, Kate I Lathrop, Marcela Mazo Canola
Nature Communications. 2024-08-07 - Student Perspectives on the Undergraduate Medical Student Research Experience at a Single United States Allopathic Institution.Michael A Deleon, Simren Lakhotia, Jonathan Gelfond, Courtney Peebles, Kate Lathrop
Cureus. 2024-05-01
Press Mentions
- Risk-Reducing Surgeries Improve Survival for Younger Patients with Breast Cancer Who Are BRCA Carriers, Study FindsJanuary 25th, 2025
- OlympiA Trial: Long-Term Benefits of Olaparib Confirmed in High-Risk Subgroup of Breast CancerJanuary 25th, 2025
- Imlunestrant Combo Improves PFS in Advanced Breast CancerDecember 11th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: